ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 5176

$984K Total Retail Price of All Prescriptions

Rank: 272 out of 5176

786 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 786 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 786 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 17,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 998 979 1 8
METOPROLOL TARTRATE 816 793 2 6
LEVOTHYROXINE SODIUM 663 597 3 4
DONEPEZIL HCL 531 519 4 28
OMEPRAZOLE 519 495 5 3
AMLODIPINE BESYLATE 466 444 6 2
NAMENDA 442 442 7 47
CITALOPRAM HBR 399 393 8 31
LISINOPRIL 374 359 9 5
TRAZODONE HCL 353 341 10 71
JANTOVEN 343 294 11 106
MIRTAZAPINE 342 332 12 45
DIVALPROEX SODIUM 341 308 13 104
METOPROLOL SUCCINATE 316 297 14 11
POLYETHYLENE GLYCOL 3350 259 249 15 74
HYDROCODONE-ACETAMINOPHEN 244 237 S3 16 27
METFORMIN HCL 242 206 17 7
DIGOXIN 239 216 18 56
POTASSIUM CHLORIDE 237 230 19 34
GABAPENTIN 223 185 20 21
CARVEDILOL 214 213 21 24
PREDNISONE 200 199 22 52
CLONIDINE HCL 193 179 23 79
TAMSULOSIN HCL 184 171 24 20
CARBIDOPA-LEVODOPA 182 179 25 98
BUMETANIDE 179 172 26 209
CYMBALTA 178 154 27 90
QUETIAPINE FUMARATE 177 173 28 75
SIMVASTATIN 170 156 29 1
RANITIDINE HCL 167 167 30 36
ISOSORBIDE MONONITRATE ER 165 165 31 44
WARFARIN SODIUM 157 157 32 13
SPIRONOLACTONE 154 151 33 88
CLOPIDOGREL 141 138 34 26
SPIRIVA 140 140 35 54
BACLOFEN 126 97 36 173
CRESTOR 125 117 37 15
ATENOLOL 125 120 37 12
KLOR-CON M20 123 121 39 129
ALLOPURINOL 121 120 40 41
GLIPIZIDE 120 120 41 63
SERTRALINE HCL 114 114 42 30
PLAVIX 109 108 43 29
LANTUS 108 107 44 66
LEVETIRACETAM 106 97 45 92
SANTYL 105 98 46 124
PRAVASTATIN SODIUM 102 101 47 23
HYDRALAZINE HCL 101 99 48 73
PANTOPRAZOLE SODIUM 94 93 49 61
CIPROFLOXACIN HCL 91 87 50 84
TRIAMCINOLONE ACETONIDE 90 83 51 125
MUPIROCIN 90 81 51 182
ROPINIROLE HCL 87 87 53 208
NITROGLYCERIN PATCH 85 85 54 149
METOCLOPRAMIDE HCL 84 80 55 176
IPRATROPIUM-ALBUTEROL 84 81 55 138
SEROQUEL 84 79 55 166
TRAMADOL HCL 82 79 58 40
FAMOTIDINE 82 69 58 58
EXELON 79 79 60 162
DOXAZOSIN MESYLATE 79 79 60 103
LIDOCAINE 77 77 62 179
LACTULOSE 76 75 63 87
HYDROCHLOROTHIAZIDE 75 74 64 10
OXCARBAZEPINE 73 68 65 379
OXYBUTYNIN CHLORIDE 70 54 66 227
LATANOPROST 70 70 66 185
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 64 68 181
TIMOLOL MALEATE 68 68 68 318
ATORVASTATIN CALCIUM 68 68 68 9
OXYCODONE-ACETAMINOPHEN 66 58 S2 71 101
LIDODERM 64 64 72 59
ADVAIR DISKUS 63 61 73 32
ESCITALOPRAM OXALATE 61 61 74 89
DILTIAZEM 24HR CD 60 60 75 119
DIOVAN 59 59 76 19
QUINAPRIL HCL 59 59 76 82
MORPHINE SULFATE 57 57 S2 78 359
NOVOLIN N 55 55 79 304
VENLAFAXINE HCL ER 55 44 79 186
CEFTRIAXONE 53 48 81 338
VALPROIC ACID 53 50 81 195
HYDROXYZINE HCL 52 52 R 83 213
PROCRIT 51 51 84 367
METHADONE HCL 51 37 S2 84 310
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.